Elizabeth Czerepak - May 18, 2022 Form 4 Insider Report for Sorrento Therapeutics, Inc. (SRNEQ)

Role
EVP & Chief Financial Officer
Signature
/s/ Henry Ji, Ph.D., as attorney-in-fact
Stock symbol
SRNEQ
Transactions as of
May 18, 2022
Transactions value $
$0
Form type
4
Date filed
5/20/2022, 05:14 PM
Previous filing
May 6, 2022
Next filing
Nov 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Stock Option (right to buy) Award $0 +350K $0.00 350K May 18, 2022 Common Stock 350K $1.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the original number of shares subject to the option shall vest on May 18, 2023, and 1/48th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.